974 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Zelenetz
    Zelenetz
  5. Perales
    Perales
  6. Horwitz
    Horwitz
  7. Schoder
    Schoder
  8. Moskowitz
    Moskowitz
  9. Noy
    Noy
  10. Portlock
    Portlock

Groups

  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)
  7. Tow Center for Developmental Oncology (TCDO) (139)
  8. Sloan Kettering Institute Faculty (133)
  9. Radiology, Department of (99)
  10. Population Sciences Research Program (94)
  1. "lymphoma"
Formats
  1. Journal Article (854)
  2. Review (54)
  3. Conference Paper (13)
  4. Editorial (13)
  5. Meeting Abstract (11)
  6. Research Letter (11)
  7. Book Section (9)
  8. Correspondence (4)
  9. Guidelines (3)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)

More Groups

People
  1. Lisa De Angelis (69)
  2. Joachim Yahalom (46)
  3. Lauren Abrey (41)
  4. Andrew Zelenetz (40)
  5. Miguel-Angel Perales (31)
  6. Steven Horwitz (28)

More People

Years
  1. 2025 (21)
  2. 2024 (43)
  3. 2023 (40)
  4. 2022 (38)
  5. 2021 (21)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Cancer (36)
  3. Leukemia and Lymphoma (36)
  4. Blood (35)
  5. Biology of Blood and Marrow Transplantation (21)
  6. Annals of Oncology (19)

More Publications

Publishers
  1. Elsevier Inc. (127)
  2. Springer (68)
  3. Wiley Blackwell (64)
  4. Lippincott Williams & Wilkins (62)
  5. Nature Publishing Group (53)
  6. American Society of Clinical Oncology (45)

More Publishers

Results (974)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal hematopoiesis in survivors of childhood cancer
    Research Letter

    Friedman, D. N.; Chan, I. C. C.; Moskowitz, C. S.; Li, S.; Turner, K.; Liu, J.; Bouvier, N.; Walsh, M. F.; Spitzer, B.; Kung, A. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
    Research Letter

    Isabelle, C.; Johnson, W. T.; McConnell, K.; Vogel, A.; Brammer, J. E.; Boles, A.; Keller, R.; Sindaco, P.; Nisenfeld, L.; Uppal, G.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Highly sensitive single tube B-lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy
    Journal Article

    Gao, Q.; Liu, Y.; Aypar, U.; Baik, J.; Londono, D.; Sun, X.; Zhang, J.; Zhang, Y.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2023)

    Fulltext@MSK | Save
  • Long-term outcomes in primary CNS lymphoma after R-MVP and high-dose chemotherapy with autologous hematopoietic stem cell transplant
    Journal Article

    Therkelsen, K. E.; Schaff, L. R.; Nandakumar, S.; Omuro, A. M. P.; Deangelis, L. M.; Grommes, C.
    Neurology (2023)

    Fulltext@MSK | Save
  • Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants
    Research Letter

    Kamboj, M.; Laracy, J. C.; Usiak, S.; Babady, N. E.; Yan, J.; Seo, S. K.
    Journal of Infection (2023)

    Fulltext@MSK | Save
  • Treatment of adult T-cell leukemia/lymphoma: Established paradigms and emerging directions
    Review

    Stuver, R.; Horwitz, S. M.; Epstein-Peterson, Z. D.
    Current Treatment Options in Oncology (2023)

    Fulltext@MSK | Save
  • Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: A CIBMTR analysis
    Journal Article

    Ragon, B. K.; Shah, M. V.; D’Souza, A.; Estrada-Merly, N.; Gowda, L.; George, G.; de Lima, M.; Hashmi, S.; Kharfan-Dabaja, M. A.; Majhail, N. S.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure
    Journal Article

    Buege, M. J.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Dao, P. H.; Matasar, M. J.
    European Journal of Haematology (2023)

    Fulltext@MSK | Save
  • (68)Ga-pentixafor PET/MRI for treatment response assessment in mantle cell lymphoma: Comparison between changes in lesion CXCR4 expression on PET and lesion size and diffusivity on MRI
    Journal Article

    Mayerhoefer, M. E.; Raderer, M.; Weber, M.; Lamm, W.; Kiesewetter, B.; Hacker, M.; Nics, L.; Schmitl, S.; Leithner, D.; Wester, H. J.; more...
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save